NRBO
Closed
Neurobo Pharmaceuticals Inc
1.89
-0.09 (-4.55%)
Last Update: 29 Jan 2025 17:30:00
Yesterday: 1.98
Day's Range: 1.75 - 2.
Send
sign up or login to leave a comment!
When Written:
0.705
Neurobo Pharmaceuticals Inc is a clinical-stage biotechnology company that focuses on developing and commercializing therapies for neurodegenerative diseases. The company's lead product candidate, NB-01, is a novel therapeutic agent being developed for the treatment of diabetic neuropathy. NB-01 is a combination of two FDA-approved drugs, which have been shown to have neuroprotective and neuroregenerative effects in preclinical studies. Neurobo Pharmaceuticals is also developing a pipeline of other drug candidates for the treatment of Alzheimer's disease, Parkinson's disease, and other neurological disorders. The company was founded in 2017 and is headquartered in Boston, Massachusetts.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








